Former Purdue Pharma Exec May Profit From Opioid Addiction Drug

Richard Sackler’s involvement with a new formulation of buprenorphine has drawn a wave of criticism.  A new formulation of buprenorphine, a medication used to treat opioid addiction, is due to hit the market—but some have taken issue with one of the inventors’ ties to Purdue Pharma, the maker of OxyContin. Richard Sackler is listed as… Continue reading Former Purdue Pharma Exec May Profit From Opioid Addiction Drug

Exit mobile version